Cowan Elvia sold PCVX
October 5, 2026 · Form 4 insider transaction
Cowan Elvia sold 19,000 shares of Vaxcyte, Inc. at $86.74 per share, a transaction worth $1.65M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
19,000
Price
$86.74
Total value
$1.65M
InsiderCowan Elvia
RoleOfficer
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 5, 2026
Filing dateOctober 7, 2026
Shares owned after27,860
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.